Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 9/20 | 0.70 |
| ▸ | PDE4A | P27815 | 6/20 | 0.70 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.70 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.70 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 12/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.67 |
| ▸ | CFTR | P13569 | 2/20 | 0.56 |
| ▸ | PDE2A | O00408 | 2/20 | 0.52 |
| ▸ | PDE1A | P54750 | 2/20 | 0.52 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.52 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.52 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.52 |
| ▸ | PDE5A | O76074 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SCN1A | P35498 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7326960 | 0.88 | ADORA2A (0.67) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL59949 | 0.85 | ADORA2B (0.72) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27396492 | 0.83 | ADORA2A (1.00) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL380135 | 0.83 | ADORA2A (1.00) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7217322 | 0.81 | ADORA2A (0.97) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4014471 | 0.80 | ADORA2A (0.63) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4423680 | 0.80 | ADORA2B (1.00) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| Phosphoric Acid SCHEMBL8500178 | 0.80 | ADORA2B (0.64) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9432917 | 0.80 | ADORA2A (0.55) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27586849 | 0.80 | ADORA2A (0.71) | ADORA2APDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2446024-A1 | MESENCHYMAL STEM CELLS GROWN UNDER HYPOXIC CONDITIONS: COMPOSITIONS, METHODS AND USES THEREFOR | Life&Light Limited (GB) | 2012-05-02 | — | — | EP | claimed |
| US-20100330047-A1 | Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor | LIFE & LIGHT LTD. (GB) | 2010-12-30 | — | — | US | claimed |
| WO-2010150094-A1 | MESENCHYMAL STEM CELLS GROWN UNDER HYPOXIC CONDITIONS: COMPOSITIONS, METHODS AND USES THEREFOR | LIFE & LIGHT LIMITED (GB) | 2010-12-29 | — | — | WO | claimed |
| WO-2010108008-A2 | BSC CELL DIFFERENTIATION AND USE IN THERAPY | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2010-09-23 | — | — | WO | claimed |
| CN-1134537-C | Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population | 四川轻化工学院 | 2004-01-14 | — | — | CN | claimed |
| CN-1287166-A | Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population | HE QINGHUA (CN) | 2001-03-14 | — | — | CN | claimed |
| US-12173323-B2 | Methods of using PDX1-positive pancreatic endoderm cells and endocrine precursor cells | VIACYTE, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240409900-A1 | CELL ENCAPSULATION DEVICE COMPRISING A PANCREATIC PROGENITOR CELL POPULATION | VIACYTE, INC. (US) | 2024-12-12 | — | — | US | disclosed |
| US-20240220740-A1 | AUTOMATIC CONSTRUCTION METHOD FOR PARALLEL CORPORA AND INFORMATION PROCESSING APPARATUS | FUJITSU LIMITED (JP) | 2024-07-04 | — | — | US | disclosed |
| EP-4394648-A1 | PARALLEL CORPUS CONSTRUCTION PROGRAM, PARALLEL CORPUS CONSTRUCTION METHOD, AND INFORMATION PROCESSING APPARATUS | FUJITSU LIMITED (JP) | 2024-07-03 | — | — | EP | disclosed |
| CN-111867634-B | Enhancement of translocation of micro/nanoparticles across mucus layers using alginate oligomers | 阿尔吉法玛公司 | 2024-06-11 | — | — | CN | disclosed |
| US-11905530-B2 | Cell encapsulation device comprising a pancreatic progenitor cell population | VIACYTE, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-11896622-B2 | Methods of producing pancreatic hormones | VIACYTE, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| CN-1287166-A | Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population | HE QINGHUA (CN) | 2001-03-14 | — | — | CN | disclosed |
| CN-1206420-A | Novel A1 adenosine receptor agonists and antagonists | UNIV FLORIDA (US) | 1999-01-27 | — | — | CN | disclosed |
| CN-1182432-A | Human neuropeptide receptor | HUMAN GENOME SCIENCES INC (US) | 1998-05-20 | — | — | CN | disclosed |
| US-5480999-A | CONTAINING AN ACID AND AN ARGININE ANALOGUE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1996-01-02 | — | — | US | disclosed |
| US-5360925-A | Cardio cerebrovascular disorders, antiinflammatory agents and immune disorders | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) | 1994-11-01 | — | — | US | disclosed |
| EP-0116938-A1 | Benzoheterocyclic carbamates | USV PHARMACEUTICAL CORPORATION (US) | 1984-08-29 | — | — | EP | disclosed |
| US-4456687-A | CULTURES; CYCLIC ADENOSINE-3'-PHOSPHATE STIMULANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1984-06-26 | — | — | US | disclosed |